Class: DeliverySystem
How a treatment's active agent is carried to its target - the formulation platform, any targeting ligand on the carrier, the receptor that ligand binds, and the cell type the carrier is aimed at. Attach via the delivery_system slot on a Treatment of any modality: the carrier is a property of the formulation, not of the payload chemistry, so an mRNA lipid nanoparticle, an albumin-bound small molecule, a liposomal cytotoxic, and a GalNAc-conjugated siRNA are all described here by the same four attributes.
Two facts that used to be inexpressible are the reason this class exists. A carrier could only be recorded inside oligonucleotide_details, so no non-oligonucleotide formulation had a home for it - nab-sirolimus and liposomal irinotecan were curated with the carrier visible only in free-text prose. And there was nowhere to say what a targeted particle is aimed at, which is the whole claim of a receptor-targeted nanomedicine: an anti-TREM2-coated mRNA lipid nanoparticle is aimed at tumor-associated macrophages, and that is a citable, falsifiable statement about the delivery system rather than about the drug.
The targeting slots are optional and an untargeted carrier is a normal record: a PEGylated liposome relies on passive accumulation and has no ligand, no receptor, and no target cell type. Leave them absent rather than asserting a target the formulation does not have.
URI: dismech:class/DeliverySystem
classDiagram
class DeliverySystem
click DeliverySystem href "../../classes/DeliverySystem/"
DeliverySystem : delivery_platform
DeliverySystem --> "0..1" DeliveryPlatformEnum : delivery_platform
click DeliveryPlatformEnum href "../../enums/DeliveryPlatformEnum/"
DeliverySystem : description
DeliverySystem : evidence
DeliverySystem --> "* _recommended_" EvidenceItem : evidence
click EvidenceItem href "../../classes/EvidenceItem/"
DeliverySystem : notes
DeliverySystem : target_cell_types
DeliverySystem --> "*" CellTypeDescriptor : target_cell_types
click CellTypeDescriptor href "../../classes/CellTypeDescriptor/"
DeliverySystem : targeting_ligand
DeliverySystem --> "0..1" TargetingLigandEnum : targeting_ligand
click TargetingLigandEnum href "../../enums/TargetingLigandEnum/"
DeliverySystem : targeting_receptor
DeliverySystem --> "0..1" GeneDescriptor : targeting_receptor
click GeneDescriptor href "../../classes/GeneDescriptor/"
Slots
| Name | Cardinality and Range | Description | Inheritance |
|---|---|---|---|
| delivery_platform | 0..1 DeliveryPlatformEnum |
How the active agent is carried to its target tissue - unformulated, ligand c... | direct |
| targeting_ligand | 0..1 TargetingLigandEnum |
Targeting ligand attached to the active agent, or to the carrier particle hol... | direct |
| targeting_receptor | 0..1 GeneDescriptor |
The cell-surface receptor or antigen that the targeting ligand binds, bindabl... | direct |
| target_cell_types | * CellTypeDescriptor |
The cell type(s) a targeted delivery system is aimed at, bindable to CL | direct |
| description | 0..1 String |
direct | |
| evidence | * recommended EvidenceItem |
direct | |
| notes | 0..1 String |
direct |
Usages
| used by | used in | type | used |
|---|---|---|---|
| Treatment | delivery_system | range | DeliverySystem |
Identifier and Mapping Information
Schema Source
- from schema: https://w3id.org/monarch-initiative/dismech
Mappings
| Mapping Type | Mapped Value |
|---|---|
| self | dismech:DeliverySystem |
| native | dismech:DeliverySystem |
LinkML Source
Direct
name: DeliverySystem
description: 'How a treatment''s active agent is carried to its target - the formulation
platform, any targeting ligand on the carrier, the receptor that ligand binds, and
the cell type the carrier is aimed at. Attach via the delivery_system slot on a
Treatment of any modality: the carrier is a property of the formulation, not of
the payload chemistry, so an mRNA lipid nanoparticle, an albumin-bound small molecule,
a liposomal cytotoxic, and a GalNAc-conjugated siRNA are all described here by the
same four attributes.
Two facts that used to be inexpressible are the reason this class exists. A carrier
could only be recorded inside oligonucleotide_details, so no non-oligonucleotide
formulation had a home for it - nab-sirolimus and liposomal irinotecan were curated
with the carrier visible only in free-text prose. And there was nowhere to say what
a targeted particle is aimed at, which is the whole claim of a receptor-targeted
nanomedicine: an anti-TREM2-coated mRNA lipid nanoparticle is aimed at tumor-associated
macrophages, and that is a citable, falsifiable statement about the delivery system
rather than about the drug.
The targeting slots are optional and an untargeted carrier is a normal record: a
PEGylated liposome relies on passive accumulation and has no ligand, no receptor,
and no target cell type. Leave them absent rather than asserting a target the formulation
does not have.'
from_schema: https://w3id.org/monarch-initiative/dismech
slots:
- delivery_platform
- targeting_ligand
- targeting_receptor
- target_cell_types
- description
- evidence
- notes
Induced
name: DeliverySystem
description: 'How a treatment''s active agent is carried to its target - the formulation
platform, any targeting ligand on the carrier, the receptor that ligand binds, and
the cell type the carrier is aimed at. Attach via the delivery_system slot on a
Treatment of any modality: the carrier is a property of the formulation, not of
the payload chemistry, so an mRNA lipid nanoparticle, an albumin-bound small molecule,
a liposomal cytotoxic, and a GalNAc-conjugated siRNA are all described here by the
same four attributes.
Two facts that used to be inexpressible are the reason this class exists. A carrier
could only be recorded inside oligonucleotide_details, so no non-oligonucleotide
formulation had a home for it - nab-sirolimus and liposomal irinotecan were curated
with the carrier visible only in free-text prose. And there was nowhere to say what
a targeted particle is aimed at, which is the whole claim of a receptor-targeted
nanomedicine: an anti-TREM2-coated mRNA lipid nanoparticle is aimed at tumor-associated
macrophages, and that is a citable, falsifiable statement about the delivery system
rather than about the drug.
The targeting slots are optional and an untargeted carrier is a normal record: a
PEGylated liposome relies on passive accumulation and has no ligand, no receptor,
and no target cell type. Leave them absent rather than asserting a target the formulation
does not have.'
from_schema: https://w3id.org/monarch-initiative/dismech
attributes:
delivery_platform:
name: delivery_platform
description: 'How the active agent is carried to its target tissue - unformulated,
ligand conjugate, lipid nanoparticle, liposome, albumin-bound particle, viral
vector. Orthogonal to targeting_ligand: an unconjugated agent may still be delivered
in a nanoparticle. Prefer the Treatment-level delivery_system block, which carries
this slot alongside the targeting detail; the copy nested in oligonucleotide_details
predates it and stays valid.'
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
alias: delivery_platform
owner: DeliverySystem
domain_of:
- OligonucleotideDetail
- DeliverySystem
range: DeliveryPlatformEnum
targeting_ligand:
name: targeting_ligand
description: 'Targeting ligand attached to the active agent, or to the carrier
particle holding it, to direct uptake by a particular tissue or cell type. Orthogonal
to delivery_platform: an unconjugated agent may still travel in a nanoparticle,
and a nanoparticle may carry a ligand on its surface.'
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
alias: targeting_ligand
owner: DeliverySystem
domain_of:
- OligonucleotideDetail
- DeliverySystem
range: TargetingLigandEnum
targeting_receptor:
name: targeting_receptor
description: The cell-surface receptor or antigen that the targeting ligand binds,
bindable to HGNC (e.g., ASGR1 for a GalNAc conjugate, TREM2 for an anti-TREM2-coated
nanoparticle). Record the receptor here and the ligand's chemical class in targeting_ligand
- they are different facts, and a receptor may be reachable by more than one
ligand.
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
alias: targeting_receptor
owner: DeliverySystem
domain_of:
- DeliverySystem
range: GeneDescriptor
inlined: true
target_cell_types:
name: target_cell_types
description: 'The cell type(s) a targeted delivery system is aimed at, bindable
to CL. This is the carrier''s intended destination, which is not always the
cell the disease mechanism runs in: a macrophage-targeted particle may be aimed
at reprogramming the macrophage rather than at the tumor cell beside it.'
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
alias: target_cell_types
owner: DeliverySystem
domain_of:
- DeliverySystem
range: CellTypeDescriptor
multivalued: true
inlined: true
inlined_as_list: true
description:
name: description
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
alias: description
owner: DeliverySystem
domain_of:
- Descriptor
- DietaryModification
- GenomicRegion
- GeneticContext
- Dataset
- ExperimentalModel
- Experiment
- ExperimentalPerturbation
- ExperimentalReadout
- ExperimentalControl
- ExecutableProtocol
- ClinicalTrial
- ComputationalModel
- ModelVariable
- DifferentialDiagnosis
- Subtype
- CausalEdge
- TreatmentMechanismTarget
- EnvironmentalMechanismTarget
- ModelDivergence
- ModelMechanismLink
- BiomarkerReadout
- PhenotypeReadout
- SurrogateEndpointCollection
- GeneClassificationCollection
- ProteinStructure
- ExternalAssertion
- EpidemiologyInfo
- Pathophysiology
- Phenotype
- HistopathologyFinding
- ImagingFinding
- Environmental
- Disease
- Stage
- AgentLifeCycle
- AgentLifeCycleStage
- AnimalModel
- Treatment
- TreatmentEffectModifier
- DeliverySystem
- InfectiousAgent
- Transmission
- Assay
- Diagnosis
- Inheritance
- Variant
- VariantPopulationEffect
- FunctionalEffect
- Mechanism
- ModelingConsideration
- Definition
- CriteriaSet
- ConditionDescriptor
- GOEnrichment
- ComorbidityHypothesis
- UpstreamConditionHypothesis
- MechanisticHypothesis
- Grouping
- GroupingCriteria
- LogicalCriterion
- DifferentiatingMechanism
- ModuleCollection
- ModuleCollectionMember
range: string
evidence:
name: evidence
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
alias: evidence
owner: DeliverySystem
domain_of:
- PhenotypeContext
- Dataset
- ExperimentalModel
- Experiment
- ExperimentalPerturbation
- ExperimentalReadout
- ExperimentalControl
- ExecutableProtocol
- ClinicalTrial
- ComputationalModel
- DifferentialDiagnosis
- Subtype
- CausalEdge
- TreatmentMechanismTarget
- EnvironmentalMechanismTarget
- ModelDivergence
- ModelMechanismLink
- BiomarkerReadout
- PhenotypeReadout
- ReferenceRange
- SurrogateEndpoint
- ExternalAssertion
- Finding
- Prevalence
- GeneCaseFraction
- GeneDiseaseValidityAssertion
- ProgressionInfo
- ClinicalBurden
- EpidemiologyInfo
- Pathophysiology
- Phenotype
- Biochemical
- HistopathologyFinding
- ImagingFinding
- Genetic
- Environmental
- Stage
- AgentLifeCycle
- AgentLifeCycleStage
- AnimalModel
- Treatment
- TreatmentEffectModifier
- DeliverySystem
- InfectiousAgent
- Transmission
- Diagnosis
- Inheritance
- Variant
- VariantPopulationEffect
- ModelingConsideration
- ClassificationAssignment
- Definition
- AlgorithmValidationStatus
- CriteriaSet
- AssociationSignal
- AssociationStatistics
- ComorbidityHypothesis
- UpstreamConditionHypothesis
- MechanisticHypothesis
- Discussion
- GroupingCriteria
- GroupingMember
- DifferentiatingMechanism
- ModuleCollection
- ModuleCollectionMember
range: EvidenceItem
recommended: true
multivalued: true
inlined: true
inlined_as_list: true
notes:
name: notes
examples:
- value: Contagious stage where symptoms appear and the bacteria can be spread
to others.
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
alias: notes
owner: DeliverySystem
domain_of:
- GeneticContext
- OnsetDescriptor
- PhenotypeContext
- Dataset
- ExperimentalModel
- Experiment
- ExperimentalPerturbation
- ExperimentalReadout
- ExperimentalControl
- ExecutableProtocol
- ClinicalTrial
- ComputationalModel
- ModelVariable
- DifferentialDiagnosis
- ReferenceRange
- SurrogateEndpoint
- SurrogateEndpointCollection
- GeneClassification
- GeneClassificationCollection
- ExternalAssertion
- TrackedIssue
- Prevalence
- GeneCaseFraction
- GeneDiseaseValidityAssertion
- ProgressionInfo
- ClinicalBurden
- EpidemiologyInfo
- Pathophysiology
- Phenotype
- Biochemical
- HistopathologyFinding
- ImagingFinding
- Genetic
- Environmental
- Disease
- Stage
- AgentLifeCycle
- AgentLifeCycleStage
- AnimalModel
- Treatment
- TreatmentEffectModifier
- DeliverySystem
- Transmission
- Diagnosis
- VariantPopulationEffect
- ClassificationAssignment
- Definition
- CriteriaSet
- TermMapping
- MappingConsistency
- ComorbidityAssociation
- AssociationSignal
- AssociationMetric
- AssociationStatistics
- MechanisticHypothesis
- Discussion
- Grouping
- GroupingCriteria
- GroupingMember
- DifferentiatingMechanism
- ModuleCollection
- ModuleCollectionMember
range: string